Neurogene (NGNE) Other Non Operating Income (2013 - 2026)
Neurogene's Other Non Operating Income was $143,000 in Q2 2026, down 88.2% from $1.21 million a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Other Non Operating Income (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurogene's Other Non Operating Income was $611,000 through Jun 30, 2026, down 68.1% year-over-year; for FY2025, it came in at $1.67 million, up 6.2% from FY2024.
- Other Non Operating Income shows a three-year compound annual growth rate of 519.6% (FY2022 to FY2025).
- In earlier years, Other Non Operating Income was $1.57 million in FY2024 (-90.4%), $16.36 million in FY2023 and $7,000 in FY2022.
- Quarterly Other Non Operating Income has moved between $3,000 (Q1 2023) and $16.34 million (Q4 2023) over five years.
- Compared with a year earlier, Other Non Operating Income was higher in three of the last seven quarters, with an average decline of 26.0%.
- Per Business Quant data, NGNE's Other Non Operating Income in the three quarters before Q2 2026 was $163,000 (Q1 2026), $156,000 (Q4 2025) and $149,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurogene | 700.15 Mn | -397.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 173,000.00 |
| Jun 30, 2026 | 150,000.00 |
| Mar 31, 2026 | 172,000.00 |
| Dec 31, 2025 | 190,000.00 |
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 558,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 677,000.00 |
| Mar 31, 2024 | 745,000.00 |
| Dec 31, 2023 | 16.37 Mn |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Mar 31, 2019 | 3,000.00 |
| Dec 31, 2018 | 1.51 Mn |
| Sep 30, 2018 | -265,000.00 |
| Jun 30, 2018 | -148,000.00 |
API Access
Neurogene Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();